Diginex's explosive growth is an illusion due to a one-time deal, and is not indicative of future growth rates. Read why DGNX stock is a sell.

Nebius will also need to take on more debt and sell more shares to fund further data center construction. Investors looking for more attractively valued AI infrastructure stocks should consider this ...

Galectin Therapeutics Inc. is rated a Hold due to absence of finalized agreement with FDA, combined with a tight runway. Read ...

If you are wondering whether Amprius Technologies is still worth chasing after its huge run up, you are not alone. This article is going to unpack exactly what the market might be pricing in. The ...